Precision Medicine

Agreements with AstraZeneca and the University of Nebraska Medical Center showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis

Clinical trial of selpercatinib shows strong response for patients with non-small cell lung cancer

System predicts tumor response to different treatments

Trial provides the strongest evidence yet that simple blood tests known as liquid biopsies can benefit women with breast cancer by tracking their disease as it evolves

Share your thoughts on the challenges and future potential of precision medicine

Join Clinical Lab Manager and our panel of experts as we discuss how clinical mass spectrometry is advancing the transition from detecting illness to quantifying wellness

UC San Diego study indicates mutant HRAS is a key, cancer-driving oncogene—and that it's a druggable target

Findings from a recent Cleveland Clinic study could guide personalized treatment for COVID-19

Researchers are using patient-derived tumor organoids to match patients with optimal treatments

New technologies are allowing physicians to make timely decisions for cancer patients